Thompson, Philip A. http://orcid.org/0000-0003-2086-6031
Peterson, Christine B.
Strati, Paolo
Jorgensen, Jeff
Keating, Michael J.
O’Brien, Susan M.
Ferrajoli, Alessandra
Burger, Jan A.
Estrov, Zeev
Jain, Nitin
Kadia, Tapan M. http://orcid.org/0000-0002-9892-9832
Borthakur, Gautam
DiNardo, Courtney D.
Daver, Naval
Jabbour, Elias
Wierda, William G.
Article History
Received: 5 October 2017
Revised: 12 February 2018
Accepted: 16 March 2018
First Online: 17 April 2018
Compliance with ethical standards
:
: P.A.T. has served as a consultant for Pharmacyclics and AbbVie and has received research funding from AbbVie. M.J.K. has served as a paid consultant for Roche/Genentech and Pharmacyclics. S.M.O. has served as a consultant for Janssen Oncology and AbbVie and has received research support from Pharmacyclics. J.A.B. has served as a consultant for Pharmacyclics and Janssen and has received research funding from Pharmacyclics. N.J. has served as a consultant for Pharmacyclics and has received research funding from Pharmacyclics and AbbVie. C.D. has received speaking fees from AbbVie. W.G.W. has served as a consultant for Pharmacyclics, AbbVie, and Roche/Genentech and has received research funding from AbbVie, Pharmacyclics, and Genentech. The remaining authors declare that they have no conflict of interest.